dr. kris on performance status in lung cancer
Published 11 years ago • 1K plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
1:28
dr. kris on sequencing challenges in lung cancer
-
1:13
dr. kris on the future of lung cancer
-
1:14
dr. kris discusses role of antiangiogenesis in lung cancer
-
1:17
dr. kris on the challenges of treating lung cancer
-
1:17
dr. kris on personalizing therapy in lung cancer
-
1:14
dr. kris describes the use of genetic testing in lung cancer
-
1:39
dr. kris on caring for elderly lung cancer patients
-
1:31
dr. kris on search for biomarkers in advanced squamous nsclc
-
1:22
dr. kris on combination chemotherapy approaches in nsclc
-
5:59
durvalumab in stage iii nsclc based on performance status
-
1:59
dr. kris on guidelines for molecular testing in lung cancer
-
1:28
dr. kris on the future of immunotherapy and targeted therapy in lung cancer
-
1:21
dr. kris on the fda approval of dacomitinib in egfr nsclc
-
1:40
dr. kris on predicting benefit with osimertinib in egfr nsclc
-
1:59
dr. kris on adjuvant systemic therapy in nsclc
-
2:20
dr. kris on the relay trial in egfr nsclc
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
1:53
dr. kris on the crizotinib clinical trials